Sutro Biopharma
STRO | NASDAQ
$9.32
-$0.50 (-5.09%)
At close: Nov 16, 2026, 4:00 PM ET
$9.32
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-5.09%
(1D)No price chart data available for 1D timeframe.
Rating
37.8
+4.0 ptsFundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #589/1021 (Top 58%)
Key Statistics
Market Data
Market Cap $154.73M
1D Range
8.34 9.64
52W Range
7.30 40.91
Valuation (TTM)
PE -0.74
PB -1.17
EV/EBITDA -2.47
Valuation (NTM)
Forward PE N/A
Forward PEG 0.01
Price Target $50.00
Cash Flow
FCF Yield -83.9%
SBC Adj. FCF Yield -88.6%
SBC Impact -5.7%
Margins
Gross Margin 94.4%
Operating Margin -255.2%
FCF Margin -287.7%
Growth (CAGR)
Revenue 3Y | 5Y -2.5% |
-5.4%
Dil EPS 3Y | 5Y 9.8% |
13.4%
FCF 3Y | 5Y -6.7% |
-26.3%
Returns
ROA -87.9%
ROE 142.7%
ROIC -88.5%
Financial Health
Net Debt
$107.13M
Current Ratio 2.94
Interest Coverage -2.89
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Sutro Biopharma, Inc. is a clinical-stage biotechnology company focused on the discovery, development, and manufacturing of innovative therapeutic products. Its primary objective is to create protein-...
Sector Healthcare
Industry Biotechnology
Employees 128
IPO Date Sep 27, 2018
Website www.sutrobio.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 12, 2026
EPS
-$1.9
Miss -15.85%
YoY:
+71.64% REV
$9.1M
Miss -35.50%
YoY:
-6.14%Next Earnings
Mar 22, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
6
Consensus
Buy
Price Target
$50.00
Upside
+436.48%
Buy (6)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove STRO